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onclusions In this large registry study, prior PCI was not associated with increased short- or mid-
erm mortality after CABG. Good outcomes can be obtained in the group of patients undergoing
ABG who have had previous PCI. (J Am Coll Cardiol Intv 2009;2:758–64) © 2009 by the American
ollege of Cardiology Foundation
rom the Departments of *Epidemiology and Preventive Medicine and †Surgery, Monash University, Victoria, Australia;
Cardiothoracic Surgery Unit, Monash Medical Centre, Victoria, Australia; §Department of Cardiothoracic Surgery, Royal
elbourne Hospital, Melbourne, Australia; Cardiothoracic Surgery Unit, Alfred Hospital, Melbourne, Australia; ¶Cardiotho-
acic Surgery Unit, Austin Hospital, Melbourne, Australia; #Cardiothoracic Care Centre, St Vincent’s Hospital, Melbourne,
ustralia; **Cardiothoracic Surgery Unit, Geelong Hospital, Victoria, Australia; and the ††Department of Medicine and
herapeutics, Chinese University of Hong Kong, Hong Kong, China. The Australasian Society of Cardiac and Thoracic Surgeons
ASCTS) Cardiac Surgery Database is an initiative of the ASCTS and is funded by the Department of Human Services, Victoria
nd the Greater Metropolitan Clinical Task Force, New South Wales, Australia.anuscript received April 6, 2009, accepted April 19, 2009.
P
t
t
w
i
a
p
s
P
a
b
s
m
i
p
c
a
w
d
p
w
r
h
t
a
m
M
S
1
l
C
b
(
P
t
a
h
o
o
o
p
s
p
A
w
A
a
S
l
1
c
p
h
T
d
p
a
o
t
m
a
w
(
h
s
w
a
C
i
i
o
a
t
w
l
c
w
d
t
b
a
o
c
d
a
w
o
p
b
t
c
s
a
i
p
a
s
d
v
J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S , V O L . 2 , N O . 8 , 2 0 0 9 Yap et al.
A U G U S T 2 0 0 9 : 7 5 8 – 6 4 Coronary Surgery After PCI
759ercutaneous coronary intervention (PCI) is emerging as
he main treatment option for coronary artery disease and
he number of PCI procedures are rapidly increasing world-
ide (1–4). The widespread use of PCI has resulted in an
ncreasing number of patients being referred for coronary
rtery bypass graft surgery (CABG) who have undergone
rior PCI. Patients with a history of prior PCI undergo
ubsequent CABG either because of failure of the original
CI (10% to 30% of patients develop in-stent restenosis
fter PCI with stent implantation) or more commonly
ecause of progression of native disease (5). The timing of
See page 765
ubsequent CABG after prior PCI is usually around 12
onths (6). One of the reasons accounting for the rapid
ncrease in PCI use is the perception that if PCI fails,
atients can safely be referred to surgery without adverse
onsequences. However, there are very little data on early
nd long-term outcomes in patients undergoing CABG
ith a history of prior PCI in the stenting era. Historical
ata in patients undergoing CABG having had previous
ercutaneous transluminal balloon angioplasty suggested
orse early mortality in this group (7). Moreover, several
eports have demonstrated worse outcomes in patients who
ave had prior PCI undergoing noncardiac surgery (8). In
his large multicenter registry report, we aim to assess the
ssociation between prior PCI and short- and mid-term
ortality after subsequent revascularization by CABG.
ethods
tudy population. The study population comprised of
3,184 consecutive patients who underwent first-time, iso-
ated CABG surgery in the ASCTS (Australasian Society of
ardiac and Thoracic Surgeons) Cardiac Surgery Database
etween June 2001 and May 2008. Patients with prior PCI
PCI group) were compared with patients without prior
CI (non-PCI group). Patients who underwent PCI during
he same admission as their CABG were excluded from the
nalysis. This was to exclude those patients who may have
ad an unsuccessful PCI necessitating CABG on an urgent
r emergent basis. Isolated CABG refers to the performance
f CABG only; those patients requiring concomitant valve
r other cardiac, such as atrial fibrillation surgery, or aortic
rocedures were thus excluded from this study.
All 6 Victorian public hospitals that perform adult cardiac
urgery—The Royal Melbourne Hospital, The Alfred Hos-
ital, Monash Medical Centre, The Geelong Hospital,
ustin Hospital, and St Vincent’s Hospital Melbourne—
ere involved in the prospective data collection for the
SCTS database during the entire study period. Addition-
lly, 8 cardiac surgical units from South Australia, New
outh Wales, and Queensland joined the database in the oast 12 months of the study period and contributed a total of
3.4% of the total patient numbers. The ASCTS database
ontained detailed information on patient demographics,
re-operative risk factors, operative details, post-operative
ospital course, and morbidity and mortality outcomes.
hese data were collected prospectively using an agreed
ataset and definitions as part of clinical care by surgeons,
erfusionists, hospital medical officers, and database man-
gers. Data collection and audit methods have been previ-
usly described (9–11). In the state of Victoria, the collec-
ion and reporting of cardiac surgery data is compulsory and
andated by the Victorian state government; hence it is
ll-inclusive. The data are subject to external audit measures
ith an overall data accuracy of 97.4% recently reported
11). The institutional review board of each participating
ospital had approved the use of these databases for re-
earch; hence, the need for individual patient consent was
aived for this study.
The study end points were in-hospital death and major
dverse cardiac events (MACE) and mid-term survival after
ABG. We defined MACE as a composite end point of
n-hospital death, myocardial
nfarction (MI), or stroke. Cause
f in-hospital death was defined
s cardiac or noncardiac. Mid-
erm survival status of patients
as obtained from the Austra-
ian National Death Index. The
losing date was June 30, 2008.
Pre-operative data analyzed
ere age; sex; the presence of
iabetes mellitus, hypercholes-
erolemia, hypertension, cere-
rovascular disease, peripheral vascular disease, renal failure,
nd respiratory disease; recent MI, congestive heart failure,
r unstable angina; New York Heart Association functional
lass; presence of left main coronary artery stenosis 50%;
egree of left ventricular impairment; and operation urgency
nd EuroSCORE value (additive). Hypercholesterolemia
as defined as a history of fasting cholesterol 5.0 mmol/l
r treatment of high cholesterol. Hypertension was blood
ressure exceeding 140/90 mm Hg or a history of high
lood pressure, or the need for antihypertensive medica-
ions. Cerebrovascular disease was any prior unresponsive
oma 24 h, stroke or transient ischemic attack, or carotid
tenosis 75%. Peripheral vascular disease was defined as
ny of the following: claudication, amputation for arterial
nsufficiency, aorto-iliac occlusive disease reconstruction or
eripheral vascular surgery, or documented abdominal aortic
neurysm. Renal failure was defined as last pre-operative
erum creatinine level 200 mol/l or pre-operative
ialysis-dependence. The most recent assessment of left
entricular function by nuclear imaging, echocardiography,
Abbreviations
and Acronyms
CABG  coronary artery
bypass graft surgery
MACE  major adverse
cardiac events
MI  myocardial infarction
PCI  percutaneous
coronary interventionr left ventricular angiography before surgery was used. Left
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760entricular ejection fraction was expressed as normal
60%) or reduced: mildly (45% to 60%), moderately (30%
o 44%), or severely (30%). Recent MI is defined as the
ccurrence of an MI within 21 days of CABG. Urgency
tatus is defined as elective, urgent (needing inpatient
urgery), and emergent (needing surgery within 24 h).
Bypass grafting strategy, perioperative management of
ntiplatelet therapy, and the choice of using cardiopulmo-
ary bypass were at the discretion of the individual surgeon.
tatistical methods. Continuous variables are presented as
ean  1 SD. Fisher exact test and Mann-Whitney U test
ere used to compare categorical and discrete variables,
espectively. Differences in in-hospital mortality and
ACE between the PCI and non-PCI groups were as-
essed using multiple variable logistic regression and pro-
ensity score methods to account for differences in patient
haracteristics. In the former, the 17 variables listed in Table
Table 1. Pre-Operative Characteristics of Patients Un
Variable
Age, yrs, mean  SD
60, %
60–69, %
70–79, %
80, %
Female sex, %
Diabetes, %
Hypercholesterolemia, %
Hypertension, %
Cerebrovascular disease, %
Peripheral vascular disease, %
Renal failure, %*
Respiratory disease, %
Myocardial infarction within 21 days, %
History of congestive heart failure, %
Unstable angina, %†
NYHA functional class, %
I
II
III
IV
Left main stenosis 50%, %
LV function, %
Normal or mild LV impairment (EF 45%)
Moderate impairment (EF 30%–45%)
Severe impairment (EF 30%)
Urgency status, %
Elective
Urgent
Emergent
*Defined as serum creatinine0.20 mmol/l. †Defined as need for intr
CABG coronary arterybypassgraft surgery; EFejection fraction; Lcoronary intervention.were forced into a multiple logistic regression model with
n-hospital mortality and MACE as the outcomes to obtain
he adjusted odds ratio (OR) for the prior PCI variable. In
he propensity score method, the 17 variables were entered
nto a stepwise logistic regression model to obtain the
ropensity score with prior PCI as the outcome variable.
he propensity score model was assessed by checking for
alance of each variable between the PCI and non-PCI
roups across quartiles of risk. The propensity score and the
rior PCI variable were then forced into a logistic regression
odel with in-hospital mortality and MACE as the out-
ome to obtain the adjusted odds ratio for the prior PCI
ariable.
Kaplan-Meier analysis was used to estimate mid-term
urvival. Differences in mid-term survival were assessed by
he log-rank test. A Cox proportional hazards model using
he 17 variables in Table 1 was constructed to assess the
ing Isolated CABG
PCI
,457)
No Prior PCI
(n  11,727) p Value
10.5 66.0  10.2 0.001
.3 27.5
.5 33.0
.8 33.5
.5 6.0
.3 22.8 0.03
.5 32.2 0.79
.2 80.2 0.001
.6 75.2 0.005
.5 11.3 0.044
.8 12.8 0.28
.8 2.7 0.74
.3 12.5 0.86
.6 24.0 0.001
.6 17.7 0.27
.3 9.9 0.06
0.38
.1 36.4
.3 36.8
.1 19.5
.6 7.3
.5 25.8 0.001
0.41
.1 68.6
.8 26.8
.1 4.7
0.002
.8 57.0
.9 38.8
.3 4.1
s nitrates until arrival in the operating theater.
ventricular;NYHANewYorkHeartAssociation; PCIpercutaneousdergo
Prior
(n  1
63.3 
37
33
24
4
20
32
87
78
9
11
2
12
15
16
8
35
37
21
6
18
70
25
4
61
34
3
avenou
V left
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761ffect of prior PCI on mid-term survival. Tests were
-sided, and p  0.05 was considered statistically signifi-
ant. Statistical analysis was performed using SPSS version
6.0 for Windows (SPSS Inc., Chicago, Illinois).
esults
ASELINE CHARACTERISTICS. Of 13,184 consecutive pa-
ients undergoing first-time isolated CABG, 1,457 (11.1%)
ad previously undergone PCI and 11,727 (88.9%) had no
revious PCI (Table 1). Patients with previous PCI were
ounger (63.3  10.5 years vs. 66.0  10.2 years, p 
.001); less likely to be female (20.3% vs. 22.8%, p  0.03),
ave cerebrovascular disease (9.5% vs. 11.3%, p 0.05), left
ain coronary artery stenosis (18.5% vs. 25.8%, p  0.001),
r recent MI (15.6% vs. 24.0%, p  0.001); or undergo
rgent CABG (34.9% vs. 38.8%, p  0.004). The lower
Table 2. Multiple Variable Logistic Regression Analysis of Variables Assoc
Variable
In-Hospital Mortality
Odds Ratio (95% CI)
Age, yrs
60 1.00
60–69 1.11 (0.66–1.89)
70–79 2.35 (1.46–3.77)
80 5.19 (2.99–9.02)
Female sex 1.40 (1.01–1.93)
Diabetes 1.23 (0.89–1.68)
Hypercholesterolemia 0.83 (0.58–1.19)
Hypertension 1.15 (0.76–1.71)
Cerebrovascular disease 1.33 (0.91–1.94)
Peripheral vascular disease 1.70 (1.19–2.42)
Renal failure* 2.32 (1.33–4.04)
Respiratory disease 1.09 (0.74–1.62)
Myocardial infarction within 21 days 1.41 (0.98–2.02)
History of congestive heart failure 2.26 (1.59–3.20)
Unstable angina† 1.62 (1.11–2.37)
NYHA functional class
I 1.00
II 0.91 (0.58–1.42)
III 1.24 (0.77–1.97)
IV 1.54 (0.93–2.55)
Left main stenosis 50% 1.32 (0.96–1.82)
Left ventricular function
Normal or mild LV impairment (EF 45%) 1.00
Moderate impairment (EF 30%–45%) 1.20 (0.84–1.71)
Severe impairment (EF 30%) 2.89 (1.87–4.47)
Urgency status
Elective 1.00
Urgent 1.82 (1.22–2.71)
Emergency 4.07 (2.28–7.24)
Prior PCI 1.26 (0.77–2.08)
*Defined as serum creatinine0.20 mmol/l. †Defined as need for intravenous nitrates until arrivalCI confidence interval; MACEmajor adverse cardiac events; other abbreviations as in Table 1.urgical risk profile of the patients who have had prior PCI
s reflected in a lower EuroSCORE value (3.6  3.0 vs. 4.4
3.3, p  0.001).
perative characteristics. Intraoperatively, patients with a
rior PCI had, on average, fewer distal coronary anastomo-
es performed (3.0  1.1 vs. 3.3  1.0, p  0.001), shorter
ross-clamp times (61.5  34.8 min vs. 68.0  35.7 min,
 0.001), and shorter bypass times (83.6  43.4 vs. 91.7
42.6 min, p  0.001). Use of the internal mammary
rtery graft was slightly lower in the PCI group (95.3% vs.
7.3%, p  0.001), as was the use of off-pump CABG
8.2% vs. 11.3%, p  0.001).
LINICAL OUTCOMES. There was no difference in unad-
usted in-hospital mortality between patients with or with-
ut previous PCI (1.65% vs. 1.55%, p  0.78). There was
o preponderance of cardiac death in either group (49% vs.
6%, p 0.67). In-hospital MACE rates were 3.0% in both
With In-Hospital Mortality and MACE
p Value
In-Hospital MACE
Odds Ratio (95% CI) p Value
— 1.00 —
0.69 1.14 (0.82–1.60) 0.43
0.001 1.81 (1.33–2.48) 0.001
0.001 2.87 (1.90–4.29) 0.001
0.04 1.09 (0.85–1.39) 0.50
0.20 1.13 (0.90–1.42) 0.29
0.32 0.83 (0.64–1.08) 0.17
0.51 1.04 (0.79–1.36) 0.79
0.14 1.64 (1.25–2.16) 0.001
0.003 1.44 (1.10–1.89) 0.008
0.003 1.83 (1.16–2.91) 0.01
0.66 0.96 (0.71–1.30) 0.80
0.06 1.36 (1.04–1.79) 0.02
0.001 1.55 (1.19–2.00) 0.001
0.01 1.49 (1.10–2.01) 0.009
— 1.00 —
0.69 1.19 (0.88–1.59) 0.25
0.37 1.35 (0.98–1.88) 0.07
0.09 1.49 (1.02–2.18) 0.04
0.08 1.16 (0.92–1.47) 0.22
— 1.00 —
0.32 1.24 (0.84–2.8) 0.61
0.001 2.89 (1.19–6.99) 0.02
— 1.00 —
0.003 1.33 (1.02–1.75) 0.04
0.001 2.86 (1.85–4.42) 0.001
0.35 1.19 (0.83–1.68) 0.34
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762roups (p 0.99). After adjusting for patient characteristics
y logistic regression, prior PCI was not an independent
redictor of in-hospital mortality (OR: 1.26, 95% confi-
ence interval [CI]: 0.77 to 2.08, p 0.35) or MACE (OR:
.19, 95% CI: 0.83 to 1.68, p  0.34) (Table 2). The
ropensity score model was well-balanced (63 of 64 vari-
bles assessed were balanced between PCI groups). Similar
esults were obtained after adjustment with propensity
core; prior PCI was not associated with in-hospital mor-
ality (OR: 1.22, 95% CI: 0.76 to 1.99, p 0.41) or MACE
OR: 1.15, 95% CI: 0.72 to 1.84, p  0.56).
Mean patient follow-up was 3.3  2.1 years (median: 3.2
ears, range 0 to 7 years). Survival at 1, 3, and 5 years was
igher in the PCI group compared with the non-PCI group
97.3% vs. 96.5%, 94.4% vs. 93.2%, and 91.1% vs. 87.7%;
og-rank test: p  0.013) (Fig. 1). After adjusting for
atient characteristics, prior PCI was not an independent
redictor of mid-term mortality (hazard ratio: 0.94, 95%
I: 0.75 to 1.18, p  0.62) (Fig. 2).
iscussion
here are several possible mechanisms by which prior PCI
ay affect the outcome of subsequent CABG. The recent
ncrease in the number of patients undergoing PCI has
timulated interest in the effect of prior PCI in these
atients.
First, prior PCI may limit the number of distal anasto-
oses, which are performed during subsequent CABG. In
Figure 1. Unadjusted Survival Post-CABG With and Without Prior PCI
At a mean patient follow-up of 3.3  2.1 years, survival was higher in the
PCI group than in the non-PCI group (1 year: 97.3% vs. 96.5%, 3 years:
94.4% vs. 93.2%, and 5 years: 91.1% vs. 87.7%; log-rank test: p  0.013).
CABG  coronary artery bypass graft surgery; PCI  percutaneous coronaryC
intervention.atients with an occluded stent, it may be technically
ifficult to graft the coronary artery distal to a stent if the
tent has been positioned in the distal portion of the vessel.
oreover, vessels with patent stents are usually not grafted
ecause graft patency rates, especially of arterial grafts, are
ignificantly reduced in the absence of significant coronary
tenosis. However, leaving vessels with patent stents un-
rafted may lead to post-operative MI should the stent
cclude given the post-operative prothrombotic state of
atients and the perioperative cessation of antiplatelet
gents. A possible solution here would be to place vein
rafts on all coronary vessels with patent stents. We do not
ave data on whether patent stented vessels were grafted in
his study.
Second, prior PCI may reduce the patency of coronary
rtery bypass grafts. This is because the distal run-off from
he graft may be compromised by multiple overlapping
tents compromising collateral blood flow or because the
urgeon is forced to graft more distal parts of the coronary
rtery due to a proximally placed stent.
Third, it has become increasingly clear that stents in
eneral and drug-eluting stents in particular may affect
oronary artery endothelial function (12,13).
Fourth, patients undergoing initial PCI may represent
cohort of patients who may have been assessed as likely
o have suboptimal outcomes from CABG, due to being
oor targets or debility out of proportion to age for
nstance. Such factors are not adjusted for as they are not
easured, thus confounding subsequent analysis of
Figure 2. Adjusted Survival Post-CABG With and Without Prior PCI
After adjusting for patient characteristics, prior PCI was not an independent
predictor of mid-term mortality (hazard ratio: 0.94, 95% CI: 0.75 to 1.18,
p  0.62). Abbreviations as in Figure 1.ABG outcomes.
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763Finally, patients who have PCI and subsequently present
or CABG may represent a cohort of patients with more
ggressive atherosclerosis (14).
For these reasons, there have been concerns in the cardiac
urgical community about the effect of prior PCI after
ubsequent CABG. These concerns have been supported by
number of reports suggesting worse outcomes after
ABG in patients with prior PCI. The earliest and largest
eport was in 6,032 patients, 15% of whom had undergone
CI prior to subsequent CABG between 1996 and 2000
rom 2 Canadian centers (15). In that study, patients with
rior PCI had greater in-hospital mortality (OR: 1.93, p 
.003) despite less comorbidity. The main limitation of that
eport was the historical nature of the data. For example,
here were no patients with drug-eluting stents. Thielmann
t al. have published 2 articles on the subject. The first
ompared 2,626 patients with no prior PCI with 679
atients with prior PCI undergoing subsequent CABG
16). The second article, a subset analysis of the first,
ompared the impact of prior PCI on 621 diabetic patients
ith triple vessel disease (17). In both these articles,
hielmann et al. reported significantly worse early mortality
nd adverse clinical events in patients with prior PCI. In the
ost recent report from the IMAGINE (Ischemia Man-
gement with Accupril Post-Bypass Graft via Inhibition of
he Converting Enzyme) study, 430 patients with prior PCI
ere compared to 2,059 patients referred to CABG without
rior PCI (18). Interestingly, that was the first article to
eport no difference in early mortality although they did
eport an increase in unstable angina requiring hospitaliza-
ion and increased coronary revascularization in the prior
CI group. The main limitation of that study, however,
emains that it is a reanalysis of data from a study not
pecifically designed to answer this question (19).
The principal finding of this analysis of a large Australian
egistry is that prior PCI was not a predictor of operative
ortality or MACE, defined as a composite end point of
n-hospital death, MI, or stroke after CABG. Similarly,
rior PCI does not negatively affect survival at a mean
ollow-up of 3.3 years after subsequent CABG. Our study
as several strengths. It is a large study with over 13,000
atients; it reports mid-term data; and because it is man-
atory, all-inclusive, registry data from multiple cardiac
urgery units it is likely to reflect real-world practice. In our
pinion, these are the principal reasons why our results differ
rom those published previously.
tudy limitations. Notwithstanding these advantages, our
tudy has certain limitations. The lack of cardiac catheter-
zation data precluded the identification of target vessels for
rior PCI and the target vessels for subsequent CABG, thus
reventing the determination of the mode of failure of PCI
i.e., restenosis vs. de novo development of occlusive lesions
t remote sites). In addition, the lack of available cardiac
atheterization data at the time of initial PCI did not allows to determine whether PCI was performed in the setting
f single-vessel or multivessel disease or whether balloon
ngioplasty alone was performed or in combination with
tent placement. Data are lacking concerning the interval
etween PCI and subsequent CABG or on the volume of
tents in place at time of CABG. Both of these variables
ay be important determinants of outcome after CABG.
inally, this study does not assess the potential for cardiac
eath or MI in the interval between initial PCI and
ubsequent surgery. Large registry studies have shown that
n the setting of multivessel disease managed with an initial
trategy of PCI, 4% to 9% of patients die within 12 months
20–22). Hence, our study does not allow us to draw
onclusions on the safety or effectiveness of a strategy of
CI first and CABG later.
onclusions
here was no association between prior PCI and short- and
id-term mortality after CABG. Good outcomes can be
btained in the group of patients undergoing CABG who
ave had previous PCI.
eprint requests and correspondence: Dr. Cheng-Hon Yap,
epartment of Cardiothoracic Surgery, The Geelong Hospital,
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